Related Experiment Video

Updated: Aug 19, 2026

Measurement of Cyclic Guanosine Monophosphate (cGMP) in Solid Tissues using Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
07:15

Measurement of Cyclic Guanosine Monophosphate (cGMP) in Solid Tissues using Competitive Enzyme-Linked Immunosorbent Assay (ELISA)

Published on: July 3, 2025

[Measurement of serum MGP]

Shuichi Jono1, Yoshiki Nishizawa

  • 1Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine.

Clinical Calcium
|March 19, 2005
PubMed

Insights

Matrix Gla protein (MGP) is an extracellular matrix protein found in blood vessels and atherosclerotic plaques. Lower serum MGP levels in cardiovascular disease patients suggest MGP may indicate disease progression.

Area of Science:

  • Biochemistry
  • Vascular Biology
  • Cardiovascular Research

Context:

  • Matrix Gla protein (MGP) is an extracellular matrix protein originating from bone tissue.
  • MGP expression is observed in both calcified and soft tissues, including normal human blood vessels and atherosclerotic plaques.
  • Elevated MGP levels are detected in human atheromatous plaques.

Purpose:

  • To investigate the role and levels of Matrix Gla protein (MGP) in cardiovascular health and disease.
  • To explore the correlation between serum MGP levels and cardiovascular disease progression.

Summary:

  • Matrix Gla protein (MGP) is expressed in vascular tissues and is found at high levels in atherosclerotic plaques.
  • Serum MGP levels are significantly decreased in patients with cardiovascular disease.
  • No significant correlation was found between serum MGP levels and bone volume.

Impact:

  • Serum MGP levels may serve as a potential biomarker for monitoring cardiovascular disease progression.
  • Findings contribute to understanding MGP's role in vascular calcification and atherosclerosis.
  • Highlights MGP as a potential target for therapeutic interventions in cardiovascular diseases.

More Related Videos

Detection and Quantification of Calcitonin Gene-Related Peptide (CGRP) in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay07:14

Detection and Quantification of Calcitonin Gene-Related Peptide (CGRP) in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay

Published on: June 16, 2023

Related Concept Videos

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...